Barry E. Greene
2016 - Alnylam Pharmaceuticals
In 2016, Barry E. Greene earned a total compensation of $1.4M as President at Alnylam Pharmaceuticals, a 73% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $218,560 |
|---|---|
| Option Awards | $620,958 |
| Salary | $546,400 |
| Other | $10,195 |
| Total | $1,396,113 |
Greene received $621K in option awards, accounting for 44% of the total pay in 2016.
Greene also received $218.6K in non-equity incentive plan, $546.4K in salary and $10.2K in other compensation.
Rankings
In 2016, Barry E. Greene's compensation ranked 6,607th out of 14,075 executives tracked by ExecPay. In other words, Greene earned more than 53.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,607 out of 14,075 | 53rd |
Division Manufacturing | 2,448 out of 5,486 | 55th |
Major group Chemicals And Allied Products | 799 out of 1,900 | 58th |
Industry group Drugs | 613 out of 1,543 | 60th |
Industry Pharmaceutical Preparations | 483 out of 1,173 | 59th |
Source: SEC filing on March 23, 2018.
Greene's colleagues
We found five more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2016.
2016
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2016
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2016
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2016
David-Alexandre Gros
Alnylam Pharmaceuticals
Former Senior Vice President, Chief Business Officer former principal financial officer
2016
Michael Mason
Alnylam Pharmaceuticals